eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
orchid pharma faces liquidation as lenders reject resolution plan
. and prevention says hepatitis a is a vaccine-preventable, communicable disease of the liver caused by a virus. it is usually transmitted person-to-person or by consuming
.
chess grandmasters show the same longevity advantage as elite athletes
.